Kimura A, Mountzouros K T, Relman D A, Falkow S, Cowell J L
Bacteriology Research Department, Praxis Biologics, Inc., Rochester, New York 14623.
Infect Immun. 1990 Jan;58(1):7-16. doi: 10.1128/iai.58.1.7-16.1990.
Filamentous hemagglutinin (FHA) is a cell surface protein of Bordetella pertussis which functions as an adhesin for this organism. It is a component of many new acellular pertussis vaccines. The proposed role of FHA in immunity to pertussis is based on animal studies which have produced some conflicting results. To clarify this situation, we reexamined the protective activity of FHA in an adult mouse respiratory infection model. Four-week-old BALB/c mice were immunized with one or two doses of 4 or 8 micrograms of FHA and then aerosol challenged with B. pertussis Tohama I. In control mice receiving tetanus toxoid, the CFU in the lungs increased from 10(5) immediately following infection to greater than 10(6) by days 5 and 9 after challenge. Mice immunized with FHA by the intraperitoneal or intramuscular route had significantly reduced bacterial colonization in the lungs. A decrease in colonization of the trachea was also observed in FHA-immunized mice. Evaluation of antibody responses in these mice revealed high titers of immunoglobulin G (IgG) and IgM to FHA in sera and of IgG to FHA in lung lavage fluids. No IgA to FHA was detected. BALB/c mice were also passively immunized intravenously with either goat or rat antibodies to FHA and then aerosol challenged 24 h later, when anti-FHA antibodies were detected in the respiratory tract. Lung and tracheal colonization was markedly reduced in mice immunized with FHA-specific antibodies compared with those receiving control antibodies. In additional studies, the role of FHA in the colonization of the mouse respiratory tract was evaluated by using strain BP101, an FHA mutant of B. pertussis. FHA was important in the initial colonization of the mouse trachea, but was not required for colonization of the trachea later in the infection. FHA was not a factor in colonization of the lungs. Collectively, these experiments demonstrate (i) that systemic immunization with FHA can provide significant protection against B. pertussis infection in both the lower and upper respiratory tract of mice as defined by the lungs and trachea, respectively; (ii) that this protection is mediated primarily by serum antibodies to FHA, which transudate into respiratory secretions; and (iii) that FHA is an important upper respiratory tract colonization factor. These studies provide further evidence for the role of FHA in pertussis pathogenesis and immunity.
丝状血凝素(FHA)是百日咳博德特氏菌的一种细胞表面蛋白,作为该菌的黏附素发挥作用。它是许多新型无细胞百日咳疫苗的一种成分。FHA在百日咳免疫中所起作用的推测是基于一些结果相互矛盾的动物研究。为了阐明这种情况,我们在成年小鼠呼吸道感染模型中重新研究了FHA的保护活性。给四周龄的BALB/c小鼠接种一剂或两剂4微克或8微克的FHA,然后用百日咳博德特氏菌Tohama I进行气溶胶攻击。在接受破伤风类毒素的对照小鼠中,肺部的菌落形成单位(CFU)在感染后立即从10⁵增加到攻击后第5天和第9天的大于10⁶。通过腹腔或肌肉途径用FHA免疫的小鼠肺部细菌定植显著减少。在FHA免疫的小鼠中还观察到气管定植减少。对这些小鼠抗体反应的评估显示,血清中针对FHA的免疫球蛋白G(IgG)和IgM以及肺灌洗液中针对FHA的IgG滴度较高。未检测到针对FHA的IgA。也给BALB/c小鼠静脉内被动免疫山羊或大鼠抗FHA抗体,然后在24小时后进行气溶胶攻击,此时在呼吸道中检测到抗FHA抗体。与接受对照抗体的小鼠相比,用FHA特异性抗体免疫的小鼠肺部和气管定植明显减少。在另外的研究中,通过使用百日咳博德特氏菌的FHA突变株BP101评估了FHA在小鼠呼吸道定植中的作用。FHA在小鼠气管的初始定植中很重要,但在感染后期气管定植中并非必需。FHA不是肺部定植的一个因素。总体而言,这些实验表明:(i)用FHA进行全身免疫可以分别针对小鼠的下呼吸道(以肺定义)和上呼吸道(以气管定义)提供针对百日咳博德特氏菌感染的显著保护;(ii)这种保护主要由针对FHA的血清抗体介导,这些抗体渗出到呼吸道分泌物中;(iii)FHA是一个重要的上呼吸道定植因子。这些研究为FHA在百日咳发病机制和免疫中的作用提供了进一步的证据。